Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBIAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TAOK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSME3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Q1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMMECR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC30A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIP13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPSB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP2K4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPSECS-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMGB3P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
F8A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on